Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Bayer discloses matrix metalloproteinase inhibitors

July 12, 1996

COX-2 inhibitors for inflammation and/or pain from Roche

July 12, 1996

Lidak reports discovery of antiinflammatory peptides

July 5, 1996

Role of adhesion receptors in chronic inflammation reviewed

July 5, 1996

Prosorba trial initiated in arthritis sufferers

July 5, 1996

Mobic introduced in Argentina

July 5, 1996

Eisai claims prostaglandin/leukotriene production inhibitors for pain and inflammation

July 5, 1996

Searle claims NOS inhibitors

July 5, 1996

Connective Therapeutic's ConXn undergoes phase II trial

June 28, 1996

Menarini's Enantyum launched in Spain

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...